Effective ex vivo generation of megakaryocytic cells from mobilized peripheral blood CD34+ cells with stem cell factor and promegapoietin

Experimental Hematology

Volumn 28, Issue 3, 2000, Pages 335-346

  Kratz Albers, Karsten ^b   Scheding, Stefan ^a   Möhle, Robert ^a   Bühring, Hans J ^a   Baum, Charles M ^c   Mc Kearn, John P ^c   Büchner, Thomas ^b   Kanz, Lothar ^a   Brugger, Wolfram ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c MONSANTO COMPANY   (United States)

Author keywords

CD34+ hematopoietic progenitor cells; CFU Meg; Ex vivo expansion; High dose chemotherapy; Megakaryocytic post progenitor cells; Megakaryocytic progenitor cells; Peripheral blood progenitor cells; Transplantation

Indexed keywords

CD34 ANTIGEN; ERYTHROPOIETIN; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 6; PROMEGAPOIETIN; RECOMBINANT ERYTHROPOIETIN; STEM CELL FACTOR; THROMBOPOIETIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MEGAKARYOCYTE; PRIORITY JOURNAL;

CELL DIFFERENTIATION; CELLS, CULTURED; GLYCOPROTEINS; GROWTH SUBSTANCES; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; MEGAKARYOCYTES; STEM CELL FACTOR; THROMBOPOIETIN;

EID: 0034053835     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00152-6     Document Type: Article

References (55)

1. Scheding S, Brugger W, Kanz L. Peripheral blood progenitor cell transplantation. In: Cytokines in the treatment of hematopoietic failure (Ganser A, Hoelzer D, eds) New York: Marcel Dekker Inc. 1998; 3, p. 51-91.
2. Scheding S, Brugger W, Kanz L. Autologous stem cell transplantation and manipulation. In: Textbook of Malignant Haematology (Degos L, Linch DC, Löwenberg B, eds) London: Martin Dunitz Ltd; 1999; 19, p.383-408.
3. Kaushansky K. Thrombopoietin. N Engl J Med. 339:1998;746.
4. Gordon M.S., McCaskill Stevens W.J., Battiato L.A., Loewy J., Loesch D., Breeden E., Hoffman R., Beach K.J., Kuca B., Kaye J.A.et al. A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood. 87:1996;3624.
5. Tepler I., Elias L., Smith J.W., Hussein M., Rosen G., Chang A.Y., Moore J.O., Gordon M.S., Kuca B., Beach K.J.et al. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood. 87:1996;3614.
6. Bertolini F., Battaglia M., Pedrazzoli P., Da P.G., Lanza A., Soligo D., Caneva L., Sarina B., Murphy S., Thomas T.et al. Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients. Blood. 89:1997;2679.
7. Birkmann J., Oez S., Smetak M., Kaiser G., Kappauf H., Gallmeier W.M. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34 + progenitor cells cultured in serum-depleted medium. Stem Cells. 15:1997;18.
8. Debili N., Masse J.M., Katz A., Guichard J., Breton-Gorius J., Vainchenker W. Effects of the recombinant hematopoietic growth factors interleukin-3, interleukin-6, stem cell factor, and leukemia inhibitory factor on the megakaryocytic differentiation of CD34 + cells. Blood. 82:1993;84.
9. Debili N., Wendling F., Katz A., Guichard J., Breton G.J., Hunt P., Vainchenker W. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood. 86:1995;2516.
10. Dolzhanskiy A., Basch R.S., Karpatkin S. The development of human megakaryocytes. III. Development of mature megakaryocytes from highly purified committed progenitors in synthetic culture media and inhibition of thrombopoietin-induced polyploidization by interleukin-3 Blood. 89:1997;426.
11. LaIuppa J.A., Papoutsakis E.T., Miller W.M. Evaluation of cytokines for expansion of the megakaryocyte and granulocyte lineages. Stem Cells. 15:1997;198.
12. Schattner M., Lefebvre P., Mingolelli S.S., Goolsby C.L., Rademaker A., White J.G., Foster D.C., Green D., Cohen I. Thrombopoietin-stimulated ex vivo expansion of human bone marrow megakaryocytes. Stem Cells. 14:1996;207.
13. Gehling U.M., Ryder J.W., Hogan C.J., Hami L., McNiece I.K., Franklin W.A., Williams S., Helm K., King J., Shpall E.J. Ex vivo expansion of megakaryocyte progenitors. effect of various growth factor combinations on CD34 + progenitor cells from bone marrow and G-CSF-mobilized peripheral blood Exp Hematol. 25:1997;1125.
14. Koizumi K., Sawada K., Yamaguchi M., Notoya A., Tarumi T., Takano H., Fukuda Y., Nishio M., Katagiri E., Yasukouchi T.et al. In vitro expansion of CD34 + /CD41 + cells from human peripheral blood CD34 +/CD41- cells. role of cytokines for in vitro proliferation and differentiation of megakaryocytic progenitors Exp Hematol. 26:1998;1140.
15. Pick M., Nagler A., Grisaru D., Eldor A., Deutsch V. Expansion of megakaryocyte progenitors from human umbilical cord blood using a new two-step separation procedure. Br J Haematol. 103:1998;639.
16. Schipper L.F., Brand A., Reniers N.C., Melief C.J., Willemze R., Fibbe W.E. Effects of thrombopoietin on the proliferation and differentiation of primitive and mature haemopoietic progenitor cells in cord blood. Br J Haematol. 101:1998;425.
17. Williams J.L., Pipia G.G., Datta N.S., Long M.W. Thrombopoietin requires additional megakaryocyte-active cytokines for optimal ex vivo expansion of megakaryocyte precursor cells. Blood. 91:1998;4118.
18. Choi E.S., Nichol J.L., Hokom M.M., Hornkohl A.C., Hunt P. Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood. 85:1995;413.
19. Dercksen W.M., Weimar I.S., Richel D.J., Breton-Gorius J., Vainchenker W., Slaper-Cortenbach I.C.M., Pinedo H.M., von dem Borne A.E.G., Gerritsen W.R., van der Schoot C.E. The value of flow cytometric analysis of platelet glycoprotein expression on CD34 + cells measured under conditions that prevent P-selectin-mediated binding of platelets. Blood. 86:1995;3771.
20. Feng R., Shimazaki C., Inaba T., Takahashi R., Hirai H., Kikuta T., Sumikuma T., Yamagata N., Ashihara E., Fujita N.et al. CD34 + /CD41a + cells best predict platelet recovery after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 21:1998;1217.
21. Nagler A., Eldor A., Naparstek E., Mumcuoglu M., Slavin S., Deutsch V. Ex vivo expansion of megakaryocyte precursors by preincubation of marrow allografts with interleukin-3 and granulocyte-macrophage colony-stimulating factor in vitro. Exp Hematol. 23:1995;1268.
22. Naparstek E., Hardan Y., Ben-Shahar M., Nagler A., Or R., Mumcuoglu M., Weiss L., Samuel S., Slavin S. Enhanced marrow recovery by short preincubation of marrow allografts with human recombinant interleukin-3 and granulocyte-macrophage colony stimulating factor. Blood. 80:1992;1673.
23. Ratajczak M.Z., Ratajczak J., Machalinski B., Mick R., Gerwitz A.M. In vitro and in vivo evidence that ex vivo cytokine priming of donor marrow cells may ameliorate posttransplant thrombocytopenia. Blood. 91:1998;353.
24. Brugger W., Heimfeld S., Berenson R.J., Mertelsmann R., Kanz L. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med. 333:1995;283.
25. Brugger W., Henschler R., Heimfeld S., Berenson R.J., Mertelsmann R., Kanz L. Positively selected autologous blood CD34 + cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood. 84:1994;1421.
26. Bokemeyer C., Harstrick A., Beyer J., Metzner B., Ruther U., Hartmann J.T., Holstein K., Derigs H.G., de W.R., Casper J.et al. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group. Semin Oncol. 25(Suppl 4):1998;24.
27. Finke J., Brugger W., Bertz H., Behringer D., Kunzmann R., Weber N.R., Kanz L., Mertelsmann R. Allogeneic transplantation of positively selected peripheral blood CD34 + progenitor cells from matched related donors. Bone Marrow Transplant. 18:1996;1081.
28. Brugger W., Mocklin W., Heimfeld S., Berenson R.J., Mertelsmann R., Kanz L. Ex vivo expansion of enriched peripheral blood CD34 + progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin. Blood. 81:1993;2579.
29. Tomer A., Harker L.A., Burstein S.A. Flow cytometric analysis of normal human megakaryocytes. Blood. 71:1988;1244.
30. Bruno E., Briddell R.A., Hoffman R. Effect of recombinant and purified hematopoietic growth factors on human megakaryocyte colony formation. Exp Hematol. 16:1988;371.
31. Briddell R.A., Brandt J.E., Straneva J., Srour E., Hoffman R. Characterization of the human burst-forming unit-megakaryocyte. Blood. 74:1989;151.
32. Scheding S., Media J.E., KuKuruga M.A., Nakeff A. In situ radiation sensitivity of recombinant human granulocyte colony-stimulating factor-recruited murine circulating blood and bone marrow progenitors (colony-forming unit [CFU]-granulocyte-macrophage and CFU-megakaryocyte). evidence for possible biologic differences between mobilized blood and bone marrow Blood. 88:1996;472.
33. Giri J., Kahn L., Doshi P.et al. Promegapoietin, an engineered chimeric growth dactor for platelet producing cells. Blood. 88:1996;1393. [Abstract].
34. Papayannopoulou T., Brice M., Farrer D., Kaushansky K. Insights into the cellular mechanisms of erythropoietin-thrombopoietin synergy. Exp Hematol. 24:1996;660.
35. Debili N., Hegyi E., Navarro S., Katz A., Mouthon M.A., Breton-Gorius J., Vainchenker W. In vitro effects of hematopoietic growth factors on the proliferation, endoreduplication, and maturation of human megakaryocytes. Blood. 77:1991;2326.
36. Kobayashi M, Imamura M, Gotohda Y, Maeda S, Iwasaki H, Sakurada K, Kasai M, Hapel AJ, Miyazaki H (1991) Synergistic effects of interleukin-1β and interleukin-3 on the expansion of human hematopoietic progenitor cells in liquid cultures. Blood 78:1947.
37. Kimura H., Ishibashi T., Shikama Y., Okano A., Akiyama Y., Uchida T., Marayuma Y. Interleukin-1β (IL-1β) induces thrombocytosis in mice. possible implications of IL-6 Blood. 76:1990;2493.
38. Hagiwara T., Kodama I., Horie K., Kato T., Miyazaki H. Proliferative properties of human umbilical cord blood megakaryocyte progenitor cells to human thrombopoietin. Exp Hematol. 26:1998;228.
39. Dolzhanskiy A., Hirst J., Basch R.S., Karpatkin S. Complementary and antagonistic effects of IL-3 in the early development of human megakaryocytes in culture. Br J Haematol. 100:1998;415.
40. Kashiwakura I., Sotiropoulos D., Adamson J.W. Ex vivo expansion of megakaryocytic colony-forming cells from human umbilical cord blood. Blood. 90:1997;538a. [Abstract].
41. Kobari L., Giarratana M.C., Poloni A., Firat H., Labopin M., Gorin N.C., Douay L. Flt 3 ligand, MGDF, Epo and G-CSF enhance ex vivo expansion of hematopoietic cell compartments in the presence of SCF, IL-3 and IL-6. Bone Marrow Transplant. 21:1998;759.
42. Maruyama M., Ito T., Takahashi T.A. Ex vivo expansion of pro-megakaryocytes (CD61 + cells) from CD34 + cells in cord blood with a combination of SCF, TPO, and Flt-3 ligand. Blood. 90:1997;536a. [Abstract].
43. Piacibello W., Garetto L., Sanavio F., Severino A., Fubini L., Stacchini A., Dragonetti G., Aglietta M. The effects of human FLT3 ligand on in vitro human megakaryocytopoiesis. Exp Hematol. 24:1996;346.
44. Kanz L, Brugger W. Mobilization and ex vivo manipulation of peripheral blood progenitor cells for support of high-dose cancer therapy. In: Hematopoietic cell transplantation (Blume KG, Thomas ED, eds) 2nd edition. Blackwell Scientific Publications; 1999; p. 455.
45. Guerriero R., Testa U., Gabbianelli M., Mattia G., Montesoro E., Macioce G., Pace A., Ziegler B., Hassan H.J., Peschle C. Unilineage megakaryocytic proliferation and differentiation of purified hematopoietic progenitors in serum-free liquid culture. Blood. 86:1995;3725.
46. Vogel W., Behringer D., Scheding S., Kanz L., Brugger W. Ex vivo expansion of CD34 + peripheral blood progenitor cells. implications for the expansion of contaminating epithelial tumor cells Blood. 88:1996;2707.
47. Spyridonidis A., Bernhardt W., Behringer D., Kohler G., Azemar M., Pflug A., Henschler R. Proliferation and survival of mammary carcinoma cells are influenced by culture conditions used for ex vivo expansion of CD34(+) blood progenitor cells. Blood. 93:1999;746.
48. Ross A.A., Loudovaris M., Hazelton B., Weaver C.H., Schwartzberg L., Bender J.G. Immunocytochemical analysis of tumor cells in pre- and post-culture peripheral blood progenitor cell collections from breast cancer patients. Exp Hematol. 23:1995;1478.
49. Mitjavila M.T., Vinci G., Villeval J.L., Kieffer N., Henri A., Testa U., Breton-Gorius J., Vainchenker W. Human platelet alpha granules contain a nonspecific inhibitor of megakaryocyte colony formation. its relationship to type beta transforming growth factor (TGF-beta) J Cell Physiol. 134:1988;93.
50. Gerwitz A.M., Calabretta B., Rucinski B., Niewiarowski S., Xu W.Y. Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide. J Clin Invest. 83:1989;1477.
51. Kuter D., Gminski D.M., Rosenberg R.D. Transforming growth factor beta inhibits megakaryocyte growth and endomitosis. Blood. 79:1992;619.
52. Berthier R., Valiron O., Schweitzer A., Marguerie G. Serum-free medium allows the optimal growth of human megakaryocyte progenitors compared with human plasma supplemented cultures. Role of TGF beta Stem Cells. 11:1993;120.
53. Reiffers J., Cailliot C., Dazey B., Attal M., Caraux J., Boiron J.M. Abrogation of post-myeloablative chemotherapy neutropenia by ex vivo-expanded autologous CD34-positive cells. Lancet. 354:1999;1092.
54. McNiece I.K., Jones R., Cagnoni P., Bearman S.I., Nieto Y., Shpall E.J. Ex vivo expansion of hematopoietic progenitor cells. preliminary results in breast cancer Hematol Cell Ther. 41:1999;82.
55. Stoney GB, Briddell RA, Kern BP, et al. (1996) Clinical scale ex vivo expansion of myeloid progenitor cells and megakaryocytes under GMP conditions [Abstract] Exp Hematol 24:1043.